https://www.selleckchem.com/pr....oducts/Adriamycin.ht
disease. Immobilization-induced hypercalcemia should remain as a differential diagnosis of patients with prolonged hospitalizations with hypercalcemia. Extensive workup of common etiologies of hypercalcemia should be considered prior to arriving at this diagnosis. Denosumab, while off-label for this usage, offers an effective treatment option for immobilization-induced hypercalcemia though it carries a risk of hypocalcemia especially among patients with renal disease. Both human immunodeficiency virus (HIV) and antiretroviral therapy
Like
Comment
Share
